| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |